Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NNOX NASDAQ:OM NASDAQ:TLSI NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNNOXNano-X Imaging$3.99-3.2%$4.00$3.60▼$11.00$230.54M1.891.47 million shs1.42 million shsOMOutset Medical$13.25-0.6%$13.91$5.85▼$25.35$235.40M2.13250,394 shs355,675 shsTLSITriSalus Life Sciences$5.02+5.7%$4.73$3.42▼$5.88$250.33M0.47153,549 shs212,809 shsZJYLJin Medical International$0.33+1.2%$0.59$0.32▼$2.44$51.54M9.4275,093 shs250,045 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNNOXNano-X Imaging0.00%+2.31%-4.09%-22.37%-33.50%OMOutset Medical0.00%+6.43%-6.49%-23.94%+40.21%TLSITriSalus Life Sciences0.00%+16.20%+2.03%+9.13%+11.80%ZJYLJin Medical International0.00%-22.53%-42.63%-50.45%-85.27%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNNOXNano-X Imaging$3.99-3.2%$4.00$3.60▼$11.00$230.54M1.891.47 million shs1.42 million shsOMOutset Medical$13.25-0.6%$13.91$5.85▼$25.35$235.40M2.13250,394 shs355,675 shsTLSITriSalus Life Sciences$5.02+5.7%$4.73$3.42▼$5.88$250.33M0.47153,549 shs212,809 shsZJYLJin Medical International$0.33+1.2%$0.59$0.32▼$2.44$51.54M9.4275,093 shs250,045 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNNOXNano-X Imaging0.00%+2.31%-4.09%-22.37%-33.50%OMOutset Medical0.00%+6.43%-6.49%-23.94%+40.21%TLSITriSalus Life Sciences0.00%+16.20%+2.03%+9.13%+11.80%ZJYLJin Medical International0.00%-22.53%-42.63%-50.45%-85.27%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNNOXNano-X Imaging 3.00Buy$8.50113.03% UpsideOMOutset Medical 2.50Moderate Buy$24.6786.16% UpsideTLSITriSalus Life Sciences 3.00Buy$10.90117.13% UpsideZJYLJin Medical International 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest ZJYL, NNOX, OM, and TLSI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025NNOXNano-X ImagingWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025OMOutset MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025TLSITriSalus Life SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025ZJYLJin Medical InternationalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/27/2025NNOXNano-X ImagingWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025OMOutset MedicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025TLSITriSalus Life SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025ZJYLJin Medical InternationalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/19/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.008/19/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSector Perform$22.008/13/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$10.00 ➝ $8.00(Data available from 10/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNNOXNano-X Imaging$11.28M20.44N/AN/A$3.27 per share1.22OMOutset Medical$113.69M2.07N/AN/A$7.49 per share1.77TLSITriSalus Life Sciences$29.43M8.51N/AN/A($0.83) per share-6.05ZJYLJin Medical International$22.83M2.24$0.03 per share13.04$0.18 per share1.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNNOXNano-X Imaging-$53.52M-$0.90N/AN/AN/A-468.29%-32.09%-28.73%11/20/2025 (Estimated)OMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)TLSITriSalus Life Sciences-$30.05M-$1.18N/AN/AN/A-86.61%N/A-116.50%11/13/2025 (Estimated)ZJYLJin Medical International$3.68MN/A0.00∞N/AN/AN/AN/AN/ALatest ZJYL, NNOX, OM, and TLSI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/13/2025Q3 2025TLSITriSalus Life Sciences-$0.17N/AN/AN/A$11.76 millionN/A11/5/2025Q3 2025OMOutset Medical-$0.64N/AN/AN/A$30.69 millionN/A8/12/2025Q2 2025NNOXNano-X Imaging-$0.15-$0.23-$0.08-$0.23$3.20 million$3.04 million8/12/2025Q2 2025TLSITriSalus Life Sciences-$0.22-$0.27-$0.05-$0.27$10.69 million$11.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNNOXNano-X ImagingN/AN/AN/AN/AN/AOMOutset MedicalN/AN/AN/AN/AN/ATLSITriSalus Life SciencesN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNNOXNano-X ImagingN/A4.194.03OMOutset Medical0.637.476.05TLSITriSalus Life SciencesN/A4.083.68ZJYLJin Medical InternationalN/A2.111.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNNOXNano-X Imaging21.49%OMOutset MedicalN/ATLSITriSalus Life Sciences2.58%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipNNOXNano-X Imaging7.74%OMOutset Medical2.40%TLSITriSalus Life Sciences27.50%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNNOXNano-X Imaging19057.78 million53.31 millionOptionableOMOutset Medical52017.77 million17.34 millionNot OptionableTLSITriSalus Life Sciences10649.87 million36.15 millionNot OptionableZJYLJin Medical International245156.55 millionN/ANot OptionableZJYL, NNOX, OM, and TLSI HeadlinesRecent News About These CompaniesJin Medical International's (ZJYL) "Hold (C-)" Rating Reiterated at Weiss RatingsOctober 8, 2025 | marketbeat.comAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comShort Interest in Jin Medical International Ltd. (NASDAQ:ZJYL) Decreases By 40.1%October 5, 2025 | marketbeat.comJin Medical International (NASDAQ:ZJYL) Will Want To Turn Around Its Return TrendsAugust 25, 2025 | finance.yahoo.comJin Medical International Reports Decline in Revenue and Profit for H1 2025August 20, 2025 | msn.comJin Medical International Ltd News (ZJYL) - Investing.comAugust 20, 2025 | investing.comJin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, ChinaJuly 15, 2025 | quiverquant.comQJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing FacilityJuly 15, 2025 | globenewswire.comJin Medical Faces Nasdaq Listing Compliance ChallengeMay 6, 2025 | tipranks.comJin Medical International Ltd. -- Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | gurufocus.comJin Medical International Ltd. – Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | globenewswire.comIs Jin Medical International Ltd.'s (NASDAQ:ZJYL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?April 28, 2025 | finance.yahoo.comJin Medical Boosts Production Capacity with New Chuzhou FacilityApril 25, 2025 | tipranks.comJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)April 13, 2025 | nasdaq.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 12.45%April 3, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 10.09%March 25, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 29.03%March 21, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 14.61%March 20, 2025 | aaii.comAWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 11.29%January 31, 2025 | aaii.comAJin Medical International Full Year 2024 Earnings: EPS: US$0.023 (vs US$0.02 in FY 2023)January 27, 2025 | finance.yahoo.comWuhan Jin Jiang International HotelNovember 12, 2024 | travelweekly.comTNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesDatavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 20253 Quantum Computing ETFs to Know—And Why 2 Don't Hold D-WaveBy Nathan Reiff | September 23, 2025After the Fed's Rate Cut, PNC Could See a Mortgage Refinance BoomBy Jordan Chussler | September 21, 2025Downgraded But Not Done: 3 Stocks Ready for a Market ComebackBy Thomas Hughes | September 24, 2025Qualcomm’s RSI Just Hit Its High of the Year—Why That’s BullishBy Sam Quirke | September 24, 2025ZJYL, NNOX, OM, and TLSI Company DescriptionsNano-X Imaging NASDAQ:NNOX$3.99 -0.13 (-3.16%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$4.04 +0.05 (+1.38%) As of 10/17/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Outset Medical NASDAQ:OM$13.25 -0.08 (-0.60%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$13.30 +0.04 (+0.34%) As of 10/17/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.TriSalus Life Sciences NASDAQ:TLSI$5.02 +0.27 (+5.68%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$4.97 -0.04 (-0.90%) As of 10/17/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.Jin Medical International NASDAQ:ZJYL$0.33 +0.00 (+1.21%) Closing price 10/17/2025 03:43 PM EasternExtended Trading$0.33 0.00 (0.00%) As of 10/17/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Intel's Turnaround Hits Hyperspeed With A New 52-Week High Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
